Daewoong Pharmaceutical said it would behavior a scientific trial on botulinum toxin Nabota for the remedy of hair loss.
The Ministry of Food and Drug Safety on Monday authorized the segment-2b take a look at on Nabota in sufferers with male pattern baldness.
Park Byung-cheol, a professor on the Dermatology Department of Dangook University Hospital, plans to evaluate the efficacy and protection of Nabota in 48 patients with male sample baldness.
Earlier, Park performed a sponsor-investigator trial to faucet the opportunity of Nabota’s efficacy to deal with hair loss. He injected 30U of Nabota into the dermis-fat border round hair follicles of the patients. The patients obtained six injections, once a month for twenty-four weeks. Park injected a complete of 180U of Nabota in line with patient to examine the hair growth effect.
The result showed that seven hairs grew according to 1㎠ of scalp six months after the Nabota remedy.
There turned into simplest one clinical trial that studied the connection between the botulinum toxin and hair loss. Although this have a look at had a clinical evaluation of the efficacy, it did not verify how the mechanism labored.
The upcoming phase-2b take a look at on Nabota might show statistically great facts, drawing attention in the pharmaceutical enterprise.
Nabota is indicated for frown strains, higher limb muscle stiffness after stroke, eye wrinkles, and eyelid twitches. Daewoong Pharmaceutical is operating on trials to widen Nabota’s indication into facial paralysis and dysfunctional tear syndrome.
The Ministry of Food and Drug Safety on Monday authorized the segment-2b take a look at on Nabota in sufferers with male pattern baldness.
Park Byung-cheol, a professor on the Dermatology Department of Dangook University Hospital, plans to evaluate the efficacy and protection of Nabota in 48 patients with male sample baldness.
Earlier, Park performed a sponsor-investigator trial to faucet the opportunity of Nabota’s efficacy to deal with hair loss. He injected 30U of Nabota into the dermis-fat border round hair follicles of the patients. The patients obtained six injections, once a month for twenty-four weeks. Park injected a complete of 180U of Nabota in line with patient to examine the hair growth effect.
The result showed that seven hairs grew according to 1㎠ of scalp six months after the Nabota remedy.
There turned into simplest one clinical trial that studied the connection between the botulinum toxin and hair loss. Although this have a look at had a clinical evaluation of the efficacy, it did not verify how the mechanism labored.
The upcoming phase-2b take a look at on Nabota might show statistically great facts, drawing attention in the pharmaceutical enterprise.
Nabota is indicated for frown strains, higher limb muscle stiffness after stroke, eye wrinkles, and eyelid twitches. Daewoong Pharmaceutical is operating on trials to widen Nabota’s indication into facial paralysis and dysfunctional tear syndrome.